{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T15:34:00Z","timestamp":1794238440291,"version":"4.9.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,9]],"date-time":"2023-11-09T00:00:00Z","timestamp":1699488000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,11,9]],"date-time":"2023-11-09T00:00:00Z","timestamp":1699488000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Key Research and Development Project of Ningxia Hui Autonomous Region Natural Science Foundation","award":["2021BEG03093"],"award-info":[{"award-number":["2021BEG03093"]}]},{"name":"Research Fund Project of Ningxia Medical University","award":["XT2022028"],"award-info":[{"award-number":["XT2022028"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>To provide a theoretical basis for the prevention and treatment of atherosclerosis (As), the current study aimed to investigate the mechanism underlying the effect of homocysteine (Hcy) on inducing the lipid deposition and foam cell formation of the vascular smooth muscle cell (VSMC) via C1q\/Tumor necrosis factor-related protein9 (CTRP9) promoter region Hypermethylation negative regulating endoplasmic reticulum stress (ERs). Therefore, apolipoprotein E deficient (ApoE<jats:sup>\u2212\/\u2212<\/jats:sup>) mice were randomly divided into the control [ApoE<jats:sup>\u2212\/\u2212<\/jats:sup>\u2009+\u2009normal diet (NC)] and high methionine [ApoE<jats:sup>\u2212\/\u2212<\/jats:sup>\u2009+\u2009(normal diet supplemented with 1.7% methionine (HMD)] groups (n\u2009=\u20096 mice\/group). Following feeding for 15\u00a0weeks, the serum levels of Homocysteine (Hcy), total cholesterol (TC), and triglyceride (TG) were measured using an automatic biochemical analyzer. HE and oil red O staining were performed on the aorta roots to observe the pathological changes. Additionally, immunofluorescence staining was performed to detect the protein expression levels of CTRP9, glucose-regulated protein 78 kD (GRP78), phosphorylated protein kinase RNA-like ER kinase (p-PERK), activating transcription factor 6a (ATF6a), phosphorylated inositol-requiring enzyme-1\u03b1 (p-IRE1\u03b1), sterol regulatory element binding proteins-1c (SREBP1c) and sterol regulatory element binding proteins-2 (SREBP2) in VSMC derived from murine aortic roots. In vitro, VSMC was stimulated with 100\u00a0\u03bcmol\/l Hcy. After transfection of plasmids with overexpression and interference of CTRP9, ERs agonist (TM) and inhibitor (4-PBA) were given to stimulate VSMC cells. HE staining and oil red O staining were used to observe the effect of Hcy stimulation on lipid deposition in VSMC. Additionally, The mRNA and protein expression levels of CTRP9, GRP78, PERK, ATF6a, IRE1\u03b1, SREBP1c, and SREBP2 in VSMC were detected by RT-qPCR and western blot analysis, respectively. Finally, The methylation modification of the CTRP9 promoter region has been studied. The NCBI database was used to search the promoter region of the CTRP9 gene, and CpG Island was used to predict the methylation site. After Hcy stimulation of VSMC, overexpression of DNMT1, and intervention with 5-Azc, assess the methylation level of the CTRP9 promoter through bisulfite sequencing PCR (BSP). The results showed that the serum levels of Hcy, TC, and TG in the ApoE<jats:sup>\u2212\/\u2212<\/jats:sup>\u2009+\u2009HMD group were significantly increased compared with the ApoE<jats:sup>\u2212\/\u2212<\/jats:sup>\u2009+\u2009NC group. In addition, HE staining and oil red O staining showed obvious AS plaque formation in the vessel wall, and a large amount of fat deposition in VSMC, thus indicating that the hyperhomocysteinemia As an animal model was successfully established. Furthermore, CTRP9 were downregulated, while GRP78, p-PERK, ATF6a, p-IRE1\u03b1, SREBP1c, SREBP2 was upregulated in aortic VSMC in the ApoE<jats:sup>\u2212\/\u2212<\/jats:sup>\u2009+\u2009HMD group. Consistent with the in vivo results, Hcy can inhibit the expression of CTRP9 in VSMC and induce ERs and lipid deposition in VSMC. Meanwhile, the increased expression of CTRP9 can reduce ERs and protect the lipid deposition in Hcy induced VSMC. Furthermore, ERs can promote Hcy induced VSMC lipid deposition, inhibition of ERs can reduce Hcy induced VSMC lipid deposition, and CTRP9 may play a protective role in Hcy induced VSMC lipid deposition and foam cell transformation through negative regulation of ERs. In addition, The CTRP9 promoter in the Hcy group showed hypermethylation. At the same time as Hcy intervention, overexpression of DNMT1 increases the methylation level of the CTRP9 promoter, while 5-Azc can reduce the methylation level of the CTRP9 promoter. Finally, Hcy can up-regulate the expression of DNMT1 and down-regulate the expression of CTRP9. After overexpression of DNMT1, the expression of CTRP9 is further decreased. After 5-Azc inhibition of DNMT1, the expression of DNMT1 decreases, while the expression of CTRP9 increases. It is suggested that the molecular mechanism of Hcy inhibiting the expression of CTRP9 is related to the hypermethylation of the CTRP9 promoter induced by Hcy and regulated by DNMT1. 5-Azc can inhibit the expression of DNMT1 and reverse the regulatory effect of DNMT1 on CTRP9. Overall, the results of the present study suggested that Hcy induces DNA hypermethylation in the CTRP9 promoter region by up-regulating DNMT1 expression, and negatively regulates ERs mediated VSMC lipid deposition and foam cell formation. CTRP9 may potentially be a therapeutic target in the treatment of hyperhomocysteinemia and As.<\/jats:p>","DOI":"10.1038\/s41598-023-46981-5","type":"journal-article","created":{"date-parts":[[2023,11,9]],"date-time":"2023-11-09T11:02:38Z","timestamp":1699527758000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Hypermethylation of the CTRP9 promoter region promotes Hcy induced VSMC lipid deposition and foam cell formation via negatively regulating ER stress"],"prefix":"10.1038","volume":"13","author":[{"given":"Xiuyu","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingbo","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minghao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,9]]},"reference":[{"key":"46981_CR1","doi-asserted-by":"publisher","first-page":"2326","DOI":"10.1093\/cvr\/cvab046","volume":"117","author":"MOJ Grootaert","year":"2021","unstructured":"Grootaert, M. O. J. & Bennett, M. R. Vascular smooth muscle cells in atherosclerosis: Time for a re-assessment. Cardiovasc. Res. 117, 2326\u20132339 (2021).","journal-title":"Cardiovasc. Res."},{"key":"46981_CR2","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.845942","volume":"9","author":"YZ Gui","year":"2022","unstructured":"Gui, Y. Z., Zheng, H. C. & Cao, Y. R. Foam cells in atherosclerosis: Novel insights into its origins, consequences, and molecular mechanisms. Front. Cardiovasc. Med. 9, 845942 (2022).","journal-title":"Front. Cardiovasc. Med."},{"issue":"12","key":"46981_CR3","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1038\/s41569-019-0227-9","volume":"16","author":"GL Basatemur","year":"2019","unstructured":"Basatemur, G. L. et al. Vascular smooth muscle cells in atherosclerosis. Nat. Rev. Cardiol. 16(12), 727\u2013744 (2019).","journal-title":"Nat. Rev. Cardiol."},{"issue":"5","key":"46981_CR4","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1161\/ATVBAHA.119.312434","volume":"39","author":"Y Wang","year":"2019","unstructured":"Wang, Y. et al. Smooth muscle cells contribute the majority of foam cells in apolipoprotein E-deficient mouse atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 39(5), 876\u2013887 (2019).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"1","key":"46981_CR5","first-page":"7","volume":"80","author":"R Guieu","year":"2022","unstructured":"Guieu, R., Ruf, J. & Mottola, G. Hyperhomocysteinemia and cardiovascular diseases. Ann. Biol. Clin. (Paris). 80(1), 7\u201314 (2022).","journal-title":"Ann. Biol. Clin. (Paris)."},{"key":"46981_CR6","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/s00418-020-01847-z","volume":"153","author":"MH Zhang","year":"2020","unstructured":"Zhang, M. H. et al. MiR-145 alleviates Hcy-induced VSMC proliferation, migration, and phenotypic switch through repression of the PI3K\/Akt\/mTOR pathway. Histochem. Cell Biol. 153, 357\u2013366 (2020).","journal-title":"Histochem. Cell Biol."},{"key":"46981_CR7","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.plipres.2018.12.002","volume":"73","author":"XH Yu","year":"2019","unstructured":"Yu, X. H. et al. Cholesterol transport system: An integrated cholesterol transport model involved in atherosclerosis. Prog. Lipid Res. 73, 65\u201391 (2019).","journal-title":"Prog. Lipid Res."},{"issue":"2","key":"46981_CR8","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1111\/febs.14740","volume":"286","author":"SJ Marciniak","year":"2019","unstructured":"Marciniak, S. J. Endoplasmic reticulum stress: A key player in human disease. FEBS J. 286(2), 228\u2013231 (2019).","journal-title":"FEBS J."},{"issue":"2","key":"46981_CR9","first-page":"137","volume":"7","author":"O Ramos-Lopez","year":"2018","unstructured":"Ramos-Lopez, O. et al. Endoplasmic reticulum stress epigenetics is related to adiposity, dyslipidemia, and insulin resistance. Adipocyte. 7(2), 137\u2013142 (2018).","journal-title":"Adipocyte."},{"issue":"5","key":"46981_CR10","doi-asserted-by":"publisher","first-page":"333","DOI":"10.3892\/mmr.2021.11972","volume":"23","author":"C Ji","year":"2021","unstructured":"Ji, C. et al. Propofol alleviates inflammation and apoptosis in HCY-induced HUVECs by inhibiting endoplasmic reticulum stress. Mol. Med. Rep. 23(5), 333 (2021).","journal-title":"Mol. Med. Rep."},{"issue":"8","key":"46981_CR11","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1002\/cbin.11805","volume":"46","author":"J Shen","year":"2022","unstructured":"Shen, J. et al. Homocysteine facilitates endoplasmic reticulum stress and apoptosis of hepatocytes by suppressing ERO1\u03b1 expression via cooperation between DNMT1 and G9a. Cell Biol. Int. 46(8), 1236\u20131248 (2022).","journal-title":"Cell Biol. Int."},{"issue":"10","key":"46981_CR12","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1093\/abbs\/gmu081","volume":"46","author":"X Yang","year":"2014","unstructured":"Yang, X. et al. Endoplasmic reticulum oxidoreductin 1\u03b1 mediates hepatic endoplasmic reticulum stress in homocysteine-induced atherosclerosis. Acta Biochim. Biophys. Sin. (Shanghai) 46(10), 902\u2013910 (2014).","journal-title":"Acta Biochim. Biophys. Sin. (Shanghai)"},{"key":"46981_CR13","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.atherosclerosis.2021.08.015","volume":"334","author":"N Zhang","year":"2021","unstructured":"Zhang, N. et al. The regulation of Ero1-alpha in homocysteine-induced macrophage apoptosis and vulnerable plaque formation in atherosclerosis. Atherosclerosis. 334, 39\u201347 (2021).","journal-title":"Atherosclerosis."},{"key":"46981_CR14","doi-asserted-by":"publisher","first-page":"2616","DOI":"10.1161\/ATVBAHA.111.231050","volume":"31","author":"Q Zheng","year":"2011","unstructured":"Zheng, Q. et al. C1q\/TNF-related proteins, a family of novel adipokines, induce vascular relaxation through the adiponectin receptor-1\/AMPK\/ eNOS\/nitric oxide signaling pathway. Arterioscler. Thromb. Vasc. Biol. 31, 2616\u20132623 (2011).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"5","key":"46981_CR15","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1007\/s00018-022-04286-2","volume":"79","author":"L Liu","year":"2022","unstructured":"Liu, L. et al. Adipokines, adiposity, and atherosclerosis. Cell Mol. Life Sci. 79(5), 272 (2022).","journal-title":"Cell Mol. Life Sci."},{"key":"46981_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.758792","volume":"12","author":"G Wang","year":"2021","unstructured":"Wang, G. et al. C1q\/TNF-related protein 9 attenuates atherosclerosis by inhibiting hyperglycemia-induced endothelial cell senescence through the AMPK\u03b1\/KLF4 signaling pathway. Front. Pharmacol. 12, 758792 (2021).","journal-title":"Front. Pharmacol."},{"issue":"1\u20132","key":"46981_CR17","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s11010-018-3473-y","volume":"455","author":"C Huang","year":"2019","unstructured":"Huang, C. et al. Overexpression of CTRP9 attenuates the development of atherosclerosis in apolipoprotein E-deficient mice. Mol. Cell Biochem. 455(1\u20132), 99\u2013108 (2019).","journal-title":"Mol. Cell Biochem."},{"issue":"4","key":"46981_CR18","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1097\/FJC.0000000000000612","volume":"72","author":"L Zhang","year":"2018","unstructured":"Zhang, L. et al. C1q\/TNF-related protein 9 inhibits THP-1 macrophage foam cell formation by enhancing autophagy. J. Cardiovasc. Pharmacol. 72(4), 167\u2013175 (2018).","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"46981_CR19","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.mce.2015.09.027","volume":"417","author":"TW Jung","year":"2015","unstructured":"Jung, T. W. et al. C1q\/TNF-related protein 9 (CTRP9) attenuates hepatic steatosis via the autophagy-mediated inhibition of endoplasmic reticulum stress. Mol. Cell Endocrinol. 417, 131\u2013140 (2015).","journal-title":"Mol. Cell Endocrinol."},{"issue":"7","key":"46981_CR20","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1038\/s41419-018-0726-3","volume":"9","author":"D Zhao","year":"2018","unstructured":"Zhao, D. et al. Cardiac-derived CTRP9 protects against myocardial ischemia\/reperfusion injury via calreticulin-dependent inhibition of apoptosis. Cell Death Dis. 9(7), 723 (2018).","journal-title":"Cell Death Dis."},{"issue":"7","key":"46981_CR21","doi-asserted-by":"publisher","first-page":"4611","DOI":"10.1111\/jcmm.14341","volume":"23","author":"L Xu","year":"2019","unstructured":"Xu, L. et al. Aberrant MFN2 transcription facilitates homocysteine-induced VSMCs proliferation via the increased binding of c-Myc to DNMT1 in atherosclerosis. J. Cell Mol. Med. 23(7), 4611\u20134626 (2019).","journal-title":"J. Cell Mol. Med."},{"key":"46981_CR22","doi-asserted-by":"publisher","first-page":"3998","DOI":"10.1016\/j.febslet.2015.11.010","volume":"589","author":"AN Yang","year":"2015","unstructured":"Yang, A. N. et al. High-methionine diets accelerate atherosclerosis by HHcy-mediated FABP4 gene demethylation pathway via DNMT1 in ApoE(\u2212\/\u2212) mice. FEBS Lett. 589, 3998\u20134009 (2015).","journal-title":"FEBS Lett."},{"key":"46981_CR23","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/s41374-021-00679-2","volume":"102","author":"LB Xu","year":"2022","unstructured":"Xu, L. B. et al. FABP4 activates the JAK2\/STAT2 pathway via Rap1a in the homocysteine-induced macrophage inflammatory response in ApoE\u2212\/\u2212 mice atherosclerosis. Lab Invest. 102, 25\u201337 (2022).","journal-title":"Lab Invest."},{"key":"46981_CR24","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.yjmcc.2019.11.145","volume":"138","author":"W Guo","year":"2020","unstructured":"Guo, W. et al. Homocysteine accelerates atherosclerosis by inhibiting scavenger receptor class B member1 via DNMT3b\/SP1 pathway. J. Mol. Cell. Cardiol. 138, 34\u201348 (2020).","journal-title":"J. Mol. Cell. Cardiol."},{"key":"46981_CR25","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak, K. J. & Schmittgen, T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(\u2212Delta Delta C(T)) method. Methods 25, 402\u2013408 (2001).","journal-title":"Methods"},{"issue":"10","key":"46981_CR26","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13485","volume":"20","author":"JT Xiong","year":"2021","unstructured":"Xiong, J. T. et al. miR-195-3p alleviates homocysteine-mediated atherosclerosis by targeting IL-31 through its epigenetics modifications. Aging Cell. 20(10), e13485 (2021).","journal-title":"Aging Cell."},{"issue":"3","key":"46981_CR27","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1111\/pin.13202","volume":"72","author":"J Fan","year":"2022","unstructured":"Fan, J. & Watanabe, T. Atherosclerosis: Known and unknown. Pathol. Int. 72(3), 151\u2013160 (2022).","journal-title":"Pathol. Int."},{"issue":"15","key":"46981_CR28","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1161\/CIRCULATIONAHA.113.005015","volume":"129","author":"S Allahverdian","year":"2014","unstructured":"Allahverdian, S. et al. Contribution of intimal smooth muscle cells to cholesterol accumulation and macrophage-like cells in human atherosclerosis. Circulation. 129(15), 1551\u20131559 (2014).","journal-title":"Circulation."},{"issue":"7","key":"46981_CR29","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1161\/CIRCRESAHA.115.304634","volume":"115","author":"F Susanne","year":"2014","unstructured":"Susanne, F. et al. Transdifferentiation of vascular smooth muscle cells to macrophage-like cells during atherogenesis. Circ. Res. 115(7), 662\u2013667 (2014).","journal-title":"Circ. Res."},{"issue":"5","key":"46981_CR30","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1097\/MOL.0000000000000113","volume":"25","author":"C Chaabane","year":"2014","unstructured":"Chaabane, C., Coen, M. & Bochaton-Piallat, M. L. Smooth muscle cell phenotypic switch: Implications for foam cell formation. Curr. Opin. Lipidol. 25(5), 374\u2013379 (2014).","journal-title":"Curr. Opin. Lipidol."},{"issue":"1","key":"46981_CR31","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/s41598-018-37407-8","volume":"9","author":"B Aliaga","year":"2019","unstructured":"Aliaga, B. et al. Universality of the DNA methylation codes in eucaryotes. Sci. Rep. 9(1), 173 (2019).","journal-title":"Sci. Rep."},{"issue":"1","key":"46981_CR32","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/npp.2012.112","volume":"38","author":"LD Moore","year":"2013","unstructured":"Moore, L. D., Le, T. & Fan, G. DNA methylation and its basic function. Neuropsychopharmacology. 38(1), 23\u201338 (2013).","journal-title":"Neuropsychopharmacology."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-46981-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-46981-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-46981-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,9]],"date-time":"2023-11-09T11:06:23Z","timestamp":1699527983000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-46981-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,9]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["46981"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-46981-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,9]]},"assertion":[{"value":"29 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"19438"}}